12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
12 health care stocks experienced significant price movements during Thursday's pre-market session, with 6 gainers and 6 losers. Aeglea BioTherapeutics, Talaris Therapeutics, T2 Biosystems, Cidara Therapeutics, Navidea Biopharmaceutical, and Predictive Oncology saw gains, while Innovative Eyewear, AlloVir, Advanced Health, Avid Bioservices, LumiraDx, and Genfit experienced losses.
June 22, 2023 | 1:13 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Advanced Health shares declined by 20.14% to $1.19, with a market cap of $33.3 million.
Advanced Health experienced a significant decrease in share price during the pre-market session, indicating negative investor sentiment and potential for further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
AlloVir shares fell 25.56% to $3.67, with a market cap of $343.4 million.
AlloVir experienced a significant decrease in share price during the pre-market session, indicating negative investor sentiment and potential for further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Avid Bioservices stock decreased by 18.57% to $12.68, with a market cap of $793.0 million. Q4 earnings were released yesterday.
Avid Bioservices experienced a significant decrease in share price during the pre-market session, likely due to the release of Q4 earnings. This indicates negative investor sentiment and potential for further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Genfit shares decreased by 11.54% to $4.14, with a market value of $206.3 million.
Genfit experienced a significant decrease in share price during the pre-market session, indicating negative investor sentiment and potential for further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
LumiraDx stock decreased by 13.1% to $0.39, with a market cap of $122.6 million.
LumiraDx experienced a significant decrease in share price during the pre-market session, indicating negative investor sentiment and potential for further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Innovative Eyewear stock declined by 42.1% to $0.8 during Thursday's pre-market session, with a market value of $6.7 million.
Innovative Eyewear experienced a significant decrease in share price during the pre-market session, indicating negative investor sentiment and potential for further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Aeglea BioTherapeutics shares rose 481.2% to $0.62 during Thursday's pre-market session, with a market cap of $40.4 million.
Aeglea BioTherapeutics experienced a significant increase in share price during the pre-market session, indicating positive investor sentiment and potential for further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Cidara Therapeutics stock moved upwards by 13.63% to $1.25, with a market value of $112.5 million.
Cidara Therapeutics saw a significant increase in share price during the pre-market session, indicating positive investor sentiment and potential for further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Navidea Biopharmaceutical stock moved upwards by 13.25% to $0.11, with a market value of $3.6 million.
Navidea Biopharmaceutical experienced a significant increase in share price during the pre-market session, indicating positive investor sentiment and potential for further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Predictive Oncology stock rose 13.14% to $4.33, with a market cap of $17.3 million.
Predictive Oncology saw a significant increase in share price during the pre-market session, indicating positive investor sentiment and potential for further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Talaris Therapeutics shares increased by 22.72% to $2.7, with a market value of $113.8 million.
Talaris Therapeutics saw a significant increase in share price during the pre-market session, indicating positive investor sentiment and potential for further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
T2 Biosystems shares increased by 17.03% to $0.08, with a market value of $2.1 million.
T2 Biosystems experienced a significant increase in share price during the pre-market session, indicating positive investor sentiment and potential for further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100